Original Article

Role of Promyelocytic Leukemia (PML) Protein in Tumor Suppression

Correspondence to: Pier Paolo Pandolfi, Department of Human Genetics, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021. Tel:212-639-6168 Fax:212-717-3374 E-mail:p-pandolfi{at}ski.mskcc.org.

The promyelocytic leukemia (PML) gene encodes a putative tumor suppressor gene involved in the control of apoptosis, which is fused to the retinoic acid receptor (RAR) gene in the vast majority of acute promyelocytic leukemia (APL) patients as a consequence of chromosomal translocations. The PMLRAR oncoprotein is thought to antagonize the function of PML through its ability to heterodimerize with and delocalize PML from the nuclear body. In APL, this may be facilitated by the reduction to heterozygosity of the normal PML allele. To determine whether PML acts as a tumor suppressor in vivo and what the consequences of deregulated programmed cell death in leukemia and epithelial cancer pathogenesis are, we crossed PML^-/- mice with human cathepsin G (hCG)-PMLRAR or mammary tumor virus (MMTV)/neu transgenic mice (TM), models of leukemia and breast cancer, respectively. The progressive reduction of the dose of PML resulted in a dramatic increase in the incidence of leukemia, and in an acceleration of leukemia onset in PMLRAR TM. By contrast, PML inactivation did not affect neu-induced tumorigenesis. In hemopoietic cells from PMLRAR TM, PML inactivation resulted in impaired response to differentiating agents such as RA and vitamin D₃ as well as in a marked survival advantage upon proapoptotic stimuli. These results demonstrate that: (a) PML acts in vivo as a tumor suppressor by rendering the cells resistant to proapoptotic and differentiating stimuli; (b) PML haploinsufficiency and the functional impairment of PML by PMLRAR are critical events in APL pathogenesis; and (c) aberrant control of programmed cell death plays a differential role in solid tumor and leukemia pathogenesis.

Key Words: promyelocytic leukemia protein, acute promyelocytic leukemia, leukemogenesis, apoptosis, transgenic mice

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Yang, S., Jeong, J.-H., Brown, A. L., Lee, C.-H., Pandolfi, P. P., Chung, J. H., Kim, M. K. (2006). Promyelocytic Leukemia Activates Chk2 by Mediating Chk2 Autophosphorylation. J. Biol. Chem. 281: 26645-26654 [Abstract] [Full Text]  
• Bellodi, C., Kindle, K., Bernassola, F., Dinsdale, D., Cossarizza, A., Melino, G., Heery, D., Salomoni, P. (2006). Cytoplasmic Function of Mutant Promyelocytic Leukemia (PML) and PML-Retinoic Acid Receptor-{alpha}. J. Biol. Chem. 281: 14465-14473 [Abstract] [Full Text]  
• Matsushita, H., Scaglioni, P. P., Bhaumik, M., Rego, E. M., Cai, L. F., Majid, S. M., Miyachi, H., Kakizuka, A., Miller, W. H. Jr., Pandolfi, P. P. (2006). In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR{alpha} blockade in the pathogenesis of acute promyelocytic leukemia. JEM 203: 821-828 [Abstract] [Full Text]  
• Xu, K., Guidez, F., Glasow, A., Chung, D., Petrie, K., Stegmaier, K., Wang, K.-K., Zhang, J., Jing, Y., Zelent, A., Waxman, S. (2005). Benzodithiophenes Potentiate Differentiation of Acute Promyelocytic Leukemia Cells by Lowering the Threshold for Ligand-Mediated Corepressor/Coactivator Exchange with Retinoic Acid Receptor {alpha} and Enhancing Changes in all-trans-Retinoic Acid-Regulated Gene Expression. Cancer Res. 65: 7856-7865 [Abstract] [Full Text]  
• Kumagai, T., Shih, L.-Y., Hughes, S. V., Desmond, J. C., O'Kelly, J., Hewison, M., Koeffler, H. P. (2005). 19-Nor-1,25(OH)2D2 (a Novel, Noncalcemic Vitamin D Analogue), Combined with Arsenic Trioxide, Has Potent Antitumor Activity against Myeloid Leukemia. Cancer Res. 65: 2488-2497 [Abstract] [Full Text]  
• Crowder, C., Dahle, O., Davis, R. E., Gabrielsen, O. S., Rudikoff, S. (2005). PML mediates IFN-{alpha}-induced apoptosis in myeloma by regulating TRAIL induction. Blood 105: 1280-1287 [Abstract] [Full Text]  
• GRISENDI, S., PANDOLFI, P.P. (2005). Two Decades of Cancer Genetics: From Specificity to Pleiotropic Networks. Cold Spring Harb Symp Quant Biol 70: 83-91 [Abstract]  
• Bernassola, F., Salomoni, P., Oberst, A., Di Como, C. J., Pagano, M., Melino, G., Pandolfi, P. P. (2004). Ubiquitin-dependent Degradation of p73 Is Inhibited by PML. JEM 199: 1545-1557 [Abstract] [Full Text]  
• Gurrieri, C., Nafa, K., Merghoub, T., Bernardi, R., Capodieci, P., Biondi, A., Nimer, S., Douer, D., Cordon-Cardo, C., Gallagher, R., Pandolfi, P. P. (2004). Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia. Blood 103: 2358-2362 [Abstract] [Full Text]  
• Dmitrovsky, E. (2004). Tissue Microarrays for Hypothesis Generation. JNCI J Natl Cancer Inst 96: 248-249 [Full Text]  
• Gurrieri, C., Capodieci, P., Bernardi, R., Scaglioni, P. P., Nafa, K., Rush, L. J., Verbel, D. A., Cordon-Cardo, C., Pandolfi, P. P. (2004). Loss of the Tumor Suppressor PML in Human Cancers of Multiple Histologic Origins. JNCI J Natl Cancer Inst 96: 269-279 [Abstract] [Full Text]  
• Hansen, L. A., Brown, D., Virador, V., Tanaka, T., Andreola, F., Strain, K., Dancheck, B., Riley, R., Arbeit, J. M., De Luca, L. M., Kogan, S., Yuspa, S. H. (2003). A PMLRARA Transgene Results in a Retinoid-deficient Phenotype Associated with Enhanced Susceptibility to Skin Tumorigenesis. Cancer Res. 63: 5257-5265 [Abstract] [Full Text]  
• Westervelt, P., Lane, A. A., Pollock, J. L., Oldfather, K., Holt, M. S., Zimonjic, D. B., Popescu, N. C., DiPersio, J. F., Ley, T. J. (2003). High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RAR{alpha} expression. Blood 102: 1857-1865 [Abstract] [Full Text]  
• Phan, V. T., Shultz, D. B., Truong, B.-T. H., Blake, T. J., Brown, A. L., Gonda, T. J., Le Beau, M. M., Kogan, S. C. (2003). Cooperation of Cytokine Signaling with Chimeric Transcription Factors in Leukemogenesis: PML-Retinoic Acid Receptor Alpha Blocks Growth Factor-Mediated Differentiation. Mol. Cell. Biol. 23: 4573-4585 [Abstract] [Full Text]  
• Sohal, J., Phan, V. T., Chan, P. V., Davis, E. M., Patel, B., Kelly, L. M., Abrams, T. J., O'Farrell, A. M., Gilliland, D. G., Le Beau, M. M., Kogan, S. C. (2003). A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657. Blood 101: 3188-3197 [Abstract] [Full Text]  
• Houghton, P. J., Adamson, P. C., Blaney, S., Fine, H. A., Gorlick, R., Haber, M., Helman, L., Hirschfeld, S., Hollingshead, M. G., Israel, M. A., Lock, R. B., Maris, J. M., Merlino, G., Patterson, W., Reynolds, C. P., Shannon, K., Yu, A., Yu, J., Smith, M. A. (2002). Testing of New Agents in Childhood Cancer Preclinical Models: Meeting Summary. Clin. Cancer Res. 8: 3646-3657 [Abstract] [Full Text]  
• Kemkemer, R., Schrank, S., Vogel, W., Gruler, H., Kaufmann, D. (2002). Increased noise as an effect of haploinsufficiency of the tumor-suppressor gene neurofibromatosis type 1 in vitro. Proc. Natl. Acad. Sci. USA 99: 13783-13788 [Abstract] [Full Text]  
• Morgan, M., Thorburn, J., Pandolfi, P. P., Thorburn, A. (2002). Nuclear and cytoplasmic shuttling of TRADD induces apoptosis via different mechanisms. JCB 157: 975-984 [Abstract] [Full Text]  
• Gaboli, M., Kotsi, P. A., Gurrieri, C., Cattoretti, G., Ronchetti, S., Cordon-Cardo, C., Broxmeyer, H. E., Hromas, R., Pandolfi, P. P. (2001). Mzf1 controls cell proliferation and tumorigenesis. Genes Dev. 15: 1625-1630 [Abstract] [Full Text]  
• Kogan, S. C., Brown, D. E., Shultz, D. B., Truong, B.-T. H., Lallemand-Breitenbach, V., Guillemin, M.-C., Lagasse, E., Weissman, I. L., Bishop, J. M. (2001). BCL-2 Cooperates with Promyelocytic Leukemia Retinoic Acid Receptor {{alpha}} Chimeric Protein (PMLRAR{{alpha}}) to Block Neutrophil Differentiation and Initiate Acute Leukemia. JEM 193: 531-544 [Abstract] [Full Text]  
• Largaespada, D. A. (2001). Haploinsufficiency for Tumor Suppression: The Hazards of Being Single and Living a Long Time. JEM 193: F15-F18 [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS